View in EDS HTML Full Text PDF Full Text

Intermittent afatinib treatment suppresses the growth of resistant T790M-H1975 cells in non-small cell lung cancer (NSCLC) co-culture.

Saved in:
Bibliographic Details
Title: Intermittent afatinib treatment suppresses the growth of resistant T790M-H1975 cells in non-small cell lung cancer (NSCLC) co-culture.
Authors: Faisal Hamdi, Amir Imran1 (AUTHOR), Poh, Wen Tsin1 (AUTHOR), Lim, Jonathan Chee Woei1 (AUTHOR), Daut, Ummi Nadira2 (AUTHOR), How, Soon Hin3 (AUTHOR), Pang, Yong Kek4 (AUTHOR), Stanslas, Johnson1 (AUTHOR) rcxjs@upm.edu.my
Source: Oncologie (De Gruyter). Nov2025, Vol. 27 Issue 6, p929-940. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:12923818
DOI:10.1515/oncologie-2025-0178